Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population

Cerebrovascular Diseases

Volumn 26, Issue 1, 2008, Pages 48-62

  Xu, Xiaowei ^a   Li, Jiejie ^a   Sheng, Wenli ^a   Liu, Lin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Gene polymorphism; Han Chinese population; Ischemic stroke; Meta analysis of genetic studies

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ARYLDIALKYLPHOSPHATASE 1; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; FIBRINOGEN; FIBRINOGEN B BETA CHAIN; METHYLENETETRAHYDROFOLATE REDUCTASE C677T; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CHINA; CHINESE; COMPUTER PROGRAM; DNA POLYMORPHISM; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; POPULATION GENETIC STRUCTURE; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE;

APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CHINA; FIBRINOGEN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; PERIODICALS AS TOPIC; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 46449125842     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000135653     Document Type: Article

References (101)

1. Wu J: Neurology, Beijing. People Health Publish 2005;7:150-153.
2. Du RP: Genetics of Chinese population. Beijing Sci Publish 2004;10:414-419.
3. He L: Decoding life - The human genome project and post Genome project. Beijing Sci Publish 2000;4:405-411.
4. Zhang GS, Dai CW: Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients and occlusive coronary artery or cerebral vascular diseases. Thromb Res 2001;104:187-195.
5. Li Z, Sun L, Zhang H, et al: Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China. Stroke 2003;34:2085-2090.
6. Casas JP, Hingorani AD, Bautista LE, et al: Meta-analysis of genetics studies in ischemic stroke. Thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 2004;61:1652-1662.
7. Bi S, Wang DS, Pan SH, et al: Analysis of ACE gene deletion polymorphism in patients with ischemic cerebrovascular diseases. Zhong Feng Yu Jing Shen Ji Bing Za Zhi 1998;15:81-83.
8. Xu YB, Wang XJ, Zhu JS, et al: Angiotensin-converting enzyme gene polymorphism and cerebrovascular disease. Zhong Hua Shen Jing Ke Za Zhi 1998;31:152-155.
9. He YS, Yao JL, Le YL: A study on the relationship between insertion/deletion polymorphism of angiotensin-converting enzyme gene and cerebrovascular disease. Zhong Guo Lin Chuang Shen Jing Ke Xue 1999;7:78-82.
10. Shi GF, Lu Y, Tang JY: Study on the polymorphism of angiotensin- converting enzyme gene in the patients with cerebral infarction. Lin Chuang Shen Jing Bing Xue Za Zhi 2000;13:19-21.
11. Zhou C, Zhang C, Luo B: Preliminary study on ACE gene deletion polymorphism in patients with cerebrovascular disease. Lin Chuang Shen Jing Bing Xue Za Zhi 2000;13:143-145.
12. Qiu XL, Zhang XL, Tang YJ, et al: Study of ACE gene and hypertension on the mechanism of CVD. Xian Dai Kang Fu 2000;4:1504.
13. Cui TP, Zhao RS, Liu CQ, et al: Polymorphism of the angiotensin- converting enzyme (ACE) and apolipoprotein exon 4 gene in patients of cerebral infarction. Zhong Guo Lao Nian Xue Za Zhi 2001;21:336-338.
14. Zhang X, Xia JH, Jin DX, et al: The relationship between angiotensin-converting enzyme gene polymorphism and risk factors for cerebral infarct. Zhong Hua Liu Xing Bing Xue Za Zhi 2001;22:435.
15. Yao LF, Liu LJ, Xu H, et al: Preliminary study about the association and its mechanism between angiotensin I-converting enzyme (ACE) gene polymorphism and cerebral vessel disease. Zhong Guo Ji Jiu Yi Xue 2002;22:585-586.
16. Yao XM, Wang JZ, Zhang ZC, et al: Relationship between recurrent cerebral infarction and angiotensin I-converting enzyme (ACE) gene polymorphism. Tian Jin Yi Yao 2002;30:672-673.
17. Zhang J, Sun XJ, Wong Q: Relationship between angiotensin-converting enzyme gene polymorphism and risk factors in cerebral infarction. Zhong Guo Lin Chuang Shen Jing Ke Xue 2002;10:361-364.
18. Li CM, Zhang C, Qiu SL, et al: Polymorphisms of ACE-1 and MTHFR genes and genetic susceptibility of ischemic stroke. Zhong Hua Yi Xue Za Zhi 2002;82:1046-1049.
19. He JL, Wang YF, Wang YH, et al: Relationship between I/D polymorphism of ACE gene and cerebrovascular diseases. Lin Chuang Shen Jing Bing Xue Za Zhi 2004;17:406-407.
20. Pan QY, Sun XF, Liao BP, et al: An analysis of the relation between angiotensin-converting enzyme (ACE) gene polymorphism and cerebral infarct and cerebral hemorrhage. Zhong Guo Xian Dai Yi Xue Za Zhi 2004;14:50-52.
21. Zhang YD, Qian M, Shi JP, et al: A study on the relationship of angiotensin-converting enzyme gene QTLs polymorphism to cerebrovascular diseases. Nao Yu Shen Jing Ji Bing Za Zhi 2004;12:323-325.
22. Gong J, Ding XS, Chen QY, et al: Analysis of ACE gene deletion polymorphism in patients with cerebrovascular diseases. Nan Jing Yi Ke Da Xue Xue Bao Zi Ran Ke Xue Ban 2005;25:890-893.
23. Teng L, Zhao YB, Wang XC, et al: Relation between MTHFR gene polymorphism and arteriosclerotic cerebral infarction. Yi Chuan 1999;21:13-16.
24. Zhang YD, Zhu ZG, Liu Y: The association of plasma Hcy level and MTHFR gene polymorphism with cerebral infarction. Zhong Feng Yu Shen Jing Ji Bing Za Zhi 2001;18:198-200.
25. Huang YN, Zhao YL, Li SW: Hyperhomocysteine, methylenetetrahydrofolate reductase gene, and other risk factors in ischemic stroke. Zhong Hua Yi Xue Za Zhi 2002;82:119-122.
26. Tu CQ, Huang MQ, Wu JZ, et al: The relation of methylenetetrahydrofolate reductase gene mutation and cystathionine β-synthase gene mutation exist in cerebral infarction. Xue Shuan Yu Zhi Xue Xue 2002;8:149-151.
27. Gao HF, Liu JG, Zhang ZC, et al: The relationship between hyperhomocysteinemia and MTHFR gene in young adult cerebral infarction patients. Tian Jin Yi Yao 2003;10:627-629.
28. Sun WP, Wan Qi, Su MQ: Genetic polymorphisms of 5,10- methylenetetrahydrofolate reductase (MTHFR) in patients with cerebral infarction. Zhong Hua Lao Nian Xin Nao Xue Guan Bing Za Zhi 2003;5:36-38.
29. Zhang Y, Xie RP, Wang YH, et al: Study about association between MTHFR gene polymorphisms and cerebral infarction. Zhong Hua Shen Jing Ke Za Zhi 2003;36:73-74.
30. Fang L, Wu YQ, Wang TW: Correlation of polymorphism of gene methylenetetrahydrofolate reductase and cystathionine betasynthase with heredity of cerebral infarction and cerebral hemorrhage in northern Chinese Han people. Zhong Guo Kang Fu Za Zhi 2004;8:4654-4656.
31. Ye H, Yan JT, Shao JM, et al: A case-control study on the relationship between stroke and plasma homocysteine level and the mutation of MTHFR gene. Zhong Hua Liu Xing Bing Xue Za Zhi 2004;25:958-962.
32. Li YJ, Huo Y, Gao XG, et al: A statistical study on the relationship between gene polymorphisms of β-fibrinogen -148C/T, N5,N10-methylene tetrahydrofolic acid reductase 677C/T and cerebral infarction. Zhong Guo Shen Jing Mian Yi Xue He Shen Jing Bing Xue Za Zhi 2005;12:363-367.
33. Qin MZ, Qin YZ: Correlation between Hcy and polymorphism of gene methylenetetrahydrofolate reductase and ischemic cerebral stroke. Zhong Guo Mei Tan Gong Ye Yi Xue Za Zhi 2005;8:474-475.
34. Xiao YQ, Jiang LL, Lu Q, et al: The relationship between the gene polymorphism of methylenetetrahydrofolate reductase and plasma homocysteine level with cerebrovascular disease. Jian Yan Yi Xue 2006;21:201-204.
35. Wang DS, Jiang L, Dai YM, et al: Primary study of ApoE gene polymorphism in patients with cerebral infarction. Zhong Feng Yu Shen Jing Ji Bing Za Zhi 1997;14:71-74.
36. Zhu TB, Zhao SP, You XK: Effect of apolipoprotein E gene on plasma levels of lipids, lipoprotein, apolipoprotein and relation to cerebral infarction. Hu Nan Yi Xue 1997;14:265-266.
37. Yan SK, Zhou X, Li XL, et al: Relationship between gene polymorphism of apolipoprotein E and serum lipids, lipoproteins, and apolipoproteins in Chinese patients with atherothrombotic brain infarction. Zhong Guo Shen Jing Mian Yi Xue He Shen Jing Bing Xue Za Zhi 1997;4:16-21.
38. Liu WG, Li ZH: The relationship between polymorphisms of apolipoprotein E gene and atherosclerotic cerebral infarction in middle-aged and young adults. Lin Chuang Shen Jing Bing Xue Za Zhi 1999;12:134-136.
39. Peng DQ, Zhao SP: Comparison of apolipoprotein E genotype distribution in two types of stroke. Zhong Guo Dong Mai Ying Hua Za Zhi 1999;7:34-36.
40. Ding J, Zhu WB, Fan W, et al: Association between apolipoprotein E polymorphisms and cerebral stroke. Zhong Guo Shen Jing Jing Shen Ji Bing Za Zhi 2000;26:371-372.
41. Wang TG, He ZY, Li YQ, et al: The relation between apolipoprotein E gene polymorphism and atherosclerotic cerebral infarction. Yi Chuan 2000;22:4-6.
42. Li ZH, Liu WG, Zhao XX, et al: Risk factors for stroke and ApoE polymorphism in the young and middle-aged. Cu Zhong Yu Shen Jing Ji Bing 2001;8:326-329.
43. Li YW, He X, Zhao LX, et al: The relationship between polymorphisms of apolipoprotein E gene and cerebrovascular disorder. Xin Nao Xue Guan Bing Fang Zhi 2001;1:17-19.
44. Shen LH, Ke KF, Li ZH, et al: Research on apolipoprotein E gene polymorphism in patients with atherosclerotic cerebral infarction. Jiao Tong Yi Xue 2002;16:504-505.
45. Xia Y, Li HL, Wang JL: Association between apolipoprotein E polymorphism and lipid metabolism in patients with cerebral infarction. Zhong Guo Bing Li Sheng Li Za Zhi 2002;18:826-829.
46. Zhu L, Cui TP: The relation of apolipoprotein E gene polymorphism and cerebral infarction. Xue Shuan Yu Zhi Xue Xue 2002;8:14-15.
47. Wang XT, Huang HJ, Ju K, et al: Apolipoprotein E gene polymorphism in people with cerebrovascular disease in the south of the Zhejiang province. Shen Jing Ji Bing Yu Jing Shen Wei Sheng 2003;3:17-19.
48. Wang JH, Ning XJ, Lu HY, et al: The study on apolipoprotein E gene polymorphism characteristics of cerebral infarction and intracerebral hemorrhage. Zhong Guo Man Xing Bing Yu Fang Yu Kong Zhi 2006;14:21-23.
49. Lv B, Zhao B, Xing YQ, et al: The study on the polymorphism of beta-fibrinogen gene -148C/T in the patients with cerebral infarction. Lin Chuang Shen Jing Bing Xue Za Zhi 2003;16:202-204.
50. Zhang XH, Xu G, Zhao XY, et al: Study of fibrinogen-β -148C/T gene polymorphism in patients with coronary heart disease and stroke. Zhong Hua Ji Zhen Yi Xue Za Zhi 2003;12:683-685.
51. Qian JJ, Liu CF, Zhao KR: The study of β-fibrinogen gene -455G/A -148C/T polymorphisms in patients with cerebral infarction. Zhong Feng Yu Shen Jing Ji Bing Za Zhi 2004;21:147-149.
52. Song YQ, Zhou HL, Song XJ, et al: Fibrinogen gene polymorphism (β -148C/T) in patients with cerebral infarction. Guo Wai Yi Xue Nao Xue Guan Ji Bing Fen Ce 2005;13:895-898.
53. Wang SJ, Yuan XD, Gao J, et al: Correlation between fibrinogen polymorphisms and the type of cerebral infarction. Zhong Hua Yi Xue Yi Chuan Xue Za Zhi 2005;22:572-574.
54. Xu F, Ni PH, Ying JY, et al: Fibrinogen-β gene -148C/T polymorphism in stroke. Zhen Duan Xue Li Lun Yu Shi Jian 2005;4:38-40.
55. Liang L, Sun C, Liao XP, et al: Analysis of the relationship between α-, and β-fibrinogen gene haplotypes and nucleotide polymorphisms associated with ischemic stroke in the Hainan Han population. Zhong Hua Yi Xue Yi Chuan Xue Za Zhi 2006;23:316-319.
56. Ma AJ, Pan XD, Zhang CS, et al: A linkage between β-fibrinogen gene -148C/T polymorphism and cerebral infarction. Zhong Hua Yi Xue Yi Chuan Xue Za Zhi 2006;23:202-204.
57. Liu Y, Pan JQ, Wang SJ: Beta-fibrinogen gene -455A/G polymorphism and plasma fibrinogen level in Chinese stroke patients. Zhong Hua Yi Xue Za Zhi 2000;8:336-338.
58. Li FQ, Liu GX, Yang ZG, et al: Effect of β-fibrinogen -455G/A gene polymorphism on plasma fibrinogen levels in patients with ischemic stroke. Zhong Guo Shi Yan Xue Ye Xue Za Zhi 2001;9:165-168.
59. Ma LY, Zhao Y, Wang XY, et al: Association of fibrinogen gene -455G/A polymorphism with ischemic stroke. Zhong Hua Lao Nian Xin Nao Xue Guan Bing Za Zhi 2001;3:96-98.
60. Zheng H, Xing YQ, Zhao B, et al: Association of β-fibrinogen gene -455G/A polymorphism and plasma fibrinogen level with acute cerebral thrombosis. Zhong Hua Xue Ye Xue Za Zhi 2001;22:151-152.
61. Zhou SN, Pan M, Ma YY, et al: The association between β Hae polymorphism located in the promoter region of β-fibrinogen gene, plasma fibrinogen levels and cerebral infarction. Nao Yu Shen Jing Ji Bing Za Zhi 2002;10:13-16.
62. Bi S, Wang DS, Li GL, et al: Relationship between β-fibrinogen promoter -455G/A (Hae) polymorphism and plasma fibrinogen of the patients with ischemic cerebrovascular disease. Zhong Hua Shen Jing Yi Xue Za Zhi 2003;2:252-256.
63. Sun H, Lu FH, Tian Q, et al: Relationship between fibrinogen-β gene (FGB) -455G/A polymorphism and atherosclerotic cerebral infarction. Zhong Hua Yi Xue Yi Chuan Xue Za Zhi 2004;21:382-385.
64. Fu Q, Xing HY, Liao XP, et al: Single nucleotide polymorphisms -455G/A, -854G/A, and -1420G/A in β-fibrinogen gene and their association with ischemic stroke. Zhong Hua Shen Jing Yi Xue Za Zhi 2005;38:565-569.
65. Zhao WJ, Yang HP, Shen YF, et al: Relationship of fibrinogen and hemorheological changes with beta-fibrinogen gene -455G/A polymorphism in patients with cerebral infarction. Zhong Guo Lin Chuang Kang Fu 2005;9:94-96.
66. Xing HY, Liao XP, Xiao F, et al: Haplotypes in the promoter region of β-fibrinogen gene and their relationship with ischemic stroke in the Han population in Hainan. Guo Ji Yi Chuan Xue Za Zhi 2006;29:328-335.
67. Zhou J, Li XX: Association of β-fibrinogen gene -455G/A polymorphism with cerebral infarction. Shen Jing Sun Shang Yu Gong Neng Chong Jian 2006;1:149-150, 160.
68. Sun Q, Zhang YD, Liu Y, et al: The study of plasma PAI-1 activity and its gene polymorphism in cerebral infarction. Nao Yu Shen Jing Ji Bing Za Zhi 2001;9:323-326.
69. Zhang C, Li J, Li L, et al: The study of PAI-1 promoter region gene polymorphism in cerebrovascular disease. Zhong Hua Yi Xue Yi Chuan Xue Za Zhi 2001;18:383-387.
70. Zhang YD, Sun Q, Liu Y, et al: The association of PAI-1 gene polymorphism with cerebral infarction and recurrent cerebral infarction. Lin Chuang Shen Jing Bing Xue Za Zhi 2001;14:262-265.
71. Zhang AJ, Song BH, Wang JX, et al: The association of PAI-1 4G/5G polymorphism with cerebral infarction. Shan Dong Yi Yao 2003;43:42-43.
72. Guan LX, Wang JX, Wang JX, et al: Effect of gene polymorphism of the PAI-1 gene promoter region on patients with essential hypertension complicated by cerebral infarction. Zhong Hua Lao Nian Yi Xue Za Zhi 2004;23:765-768.
73. Yi GH: A study of the plasma plasminogen activator inhibitor-1 activity and its promoter region gene polymorphism in acute cerebral infarction. Qing Dao Da Xue Yi Xue Yuan Xue Bao 2004;40:229-231.
74. Xu B, Zhang CY, Xian BX: A study of the plasma plasminogen activator inhibitor-1 activity and its promoter region 4G/5G gene polymorphism in acute cerebral infarction. Zhong Guo Yi Shi Jin Xiu Za Zhi 2006;29:26-28.
75. Chen JH, Zeng QX: Relationship between the paraoxonase gene 192 polymorphism and atherosclerotic cerebral infarction. Zhong Guo Lin Chuang Kang Fu 2003;7:3036-3037.
76. Huang Q, Liu YH, Yang Q, et al: The association of PON1 Q192R gene polymorphism with atherosclerotic cerebral infarction. Zhong Hua Shen Jing Ke Za Zhi 2005;38:454-455.
77. Wu J, Zhao SP, Tan LM, et al: The relationship between PON1-192 polymorphism and type of cerebral infarction. Nao Yu Shen Jing Ji Bing Za Zhi 2005;13:253-255.
78. Yu LT, Yu DC, Li L, et al: The relationship between paraoxonase gene 192Gln/Arg polymorphism and ischemic cerebrovascular disease. Zhong Hua Lao Nian Xin Nao Xue Guan Bing Za Zhi 2005;7:254-256.
79. Chen WR, Xiao ZJ, Zhao SQ, et al: The relationship between the gene polymorphism in paraoxonase and lacunar infarction. Cu Zhong Yu Shen Jing Ji Bing 2006;13:75-78.
80. Gormley K, Bevan S, Markus HS: Polymorphisms in genes of the renin-angiotensin system and cerebral small vessel disease. Cerebrovasc Dis 2007;23:148-155.
81. Banerjee I, Gupta V, Ganesh S: Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: a meta-analysis. J Hum Genet 2007;52:205-219.
82. Tiret L, Rigat B, Visvikis S, et al: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin 1-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
83. Sharma P, Carter ND, Barley J, et al: Polymorphisms in the gene encoding angiotensin 1-converting enzyme and relationship to its post-translational product in cerebral infarction. J Hum Hypertens 1994;8:633-634.
84. Agerholm-Larsen B, Nordestgaard BG, Tybjaery-Hansen A: ACE gene polymorphisms in cardiovascular disease: meta-analysis of small and large studies in whites. Arterioscler Thromb Vasc Biol 2000;20:484-492.
85. Kang SS, Wong PW, Bock HG, et al: Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am J Hum Genet 1991;48:546-551.
86. Frosst P, Blom HJ, Milos R, et al: A candidate genetic risk factor for vascular disease: a common mutation in methylene tetrahydrofolate reductase. Nat Genet 1995;10:111-113.
87. Klerk M, Verhoef P, Clarke R, et al, MTHFR Studies Collaboration Group: MTHFR 677C → T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002;288:2023-2031.
88. Cerratoa P, Baimaa C, Grassoa MA, et al: Apolipoprotein E polymorphism and stroke subtypes in an Italian cohort. Cerebrovasc Dis 2005;20:264-269.
89. Eichner JE, Dunn ST, Perveen G, et al: Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002;155:487-495.
90. Keavney B, Parish S, Palmer A, et al: Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E ε2/ε3/ε 4 genotype. Lancet 2003;361:396-398.
91. Dawson S, Henney A: The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review. Atherosclerosis 1992;95:105-117.
92. Brown NJ, Murphey LJ, Srikuma N, et al: Interactive effect of PAI-1 4G/5G genotype and salt intake on PAI-1 antigen. Arterioscler Thromb Vasc Biol 2001;21:1071-1077.
93. Bang CO, Park HK, Ahn MY, et al: 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke. Cerebrovasc Dis 2001;11:294-299.
94. Yu S, Sher B, Kudryk B, et al: Fibrinogen precursors: order of assembly of fibrinogen chains. J Biol Chem 1984;259:10574-10581.
95. Roy S, Overton O, Redman C, et al: Overexpression of any fibrinogen chain by Hep G2 cells specifically elevates the expression of the other two chains. J Biol Chem 1994;269:691-695.
96. Brown ET, Fuller GM: Detection of a complex that associates with the β-fibrinogen G455A polymorphism. Blood 1998;92:3286-3293.
97. Montgomery HE, Clarkson P, Nwose OM, et al: The acute rise in plasma fibrinogen concentration with exercise is influenced by the G455A polymorphism of the β-fibrinogen gene. Arterioscler Thromb Vasc Biol 1996;16:386-391.
98. Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE, et al: A common mutation (G-455-> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. J Clin Invest 1997;99:3034-3039.
99. Yu Q, Safavi F, Roberts R, et al: A variant of β-fibrinogen is a genetic risk factor for coronary artery disease and myocardial infarction. J Investig Med 1996;44:154-159.
100. Behague I, Poirier O, Nicaud V, et al: β-Fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction: the ECTIM study. Circulation 1996;93:440-449.
101. Lowe GOD: Blood rheology in arterial disease. Clin Sci 1986;71:137-146.